Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma
Clinical trial NCT02269085 · TERMINATED
Trial details
- NCT number
- NCT02269085
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-20
- Primary completion
- 2018-05-29
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.